Delivery Order SPE2DB25D9768-SPE2DB25FTTTL
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,225.60 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of IOSAT 130 mg tablets in quantities of 14. The contract, issued on September 10, 2025, with an ultimate completion date of September 11, 2025, utilizes firm fixed-price pricing and carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's...
- The Defense Logistics Agency awarded a delivery order valued at $7,844.17 to DMS Pharmaceutical Group Inc. on March 18, 2025, for the supply of IOSAT 130 mg tablets (14-count packaging). This is a firm fixed-price delivery order with an ultimate completion date of March 19, 2025, and represents a small pharmaceutical supply requirement for federal healthcare operations. The contract carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on an open basis despite its status...
- The U.S. Defense Logistics Agency (DLA), through its Medical Supply Chain division, awarded a delivery order to DMS Pharmaceutical Group Inc. for IOSAT 130 MG tablets in a 14-count package on September 22, 2025. This firm fixed-price delivery order, valued at $2,822.40, is set to be completed by September 23, 2025, with performance taking place at the contractor's facility in Park Ridge, Illinois. The award carries no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,398.60 contract is for the delivery of IOSAT 130 MG TABLET 14S and has an August 22, 2023 completion date. This delivery order is issued under DMS Pharmaceutical Group's existing indefinite delivery contract 4600082013 with the Defense Logistics...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,419.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of IOSAT 130 mg tablets in quantities of 14. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 23, 2025, and was awarded on September 22, 2025. No set-aside designation was utilized for this procurement. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,612.80 to DMS Pharmaceutical Group Inc. for IOSAT 130 mg tablets (14-count packaging) on August 8, 2025, with completion scheduled for August 11, 2025. This firm fixed-price delivery order was issued without a set-aside designation to the woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award represents a routine pharmaceutical supply transaction under DMS Pharmaceutical Group's existing...
- The U.S. Defense Logistics Agency Troop Support Medical has awarded a firm fixed-price delivery order contract worth $13,708.97 to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract is for the delivery of IOSAT 130 MG TABLET 14S, with a completion date of February 12, 2024. This delivery order is placed against DMS Pharmaceutical Group's existing indefinite delivery contract 4600082013 under the SPE2DB program, which has a total potential...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,016.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of IOSAT 130 mg tablets in quantities of 14. The contract, issued on August 25, 2025, with an ultimate completion date of August 26, 2025, utilizes a firm fixed-price model with no set-aside designation. This delivery order is executed under DMS Pharmaceutical Group's larger...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,612.80 by the Defense Logistics Agency on August 12, 2025, for IOSAT 130 mg tablets (14-count package). This firm fixed-price delivery order, with an ultimate completion date of August 13, 2025, is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA's SPE2DB program, valued at approximately $500 million and...
- This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,027.10 firm fixed-price delivery order is for the supply of IOSAT 130 MG TABLET 14S, a pharmaceutical product, with an ultimate completion date of October 11, 2024. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group Inc. with the DLA...
- SPE2DB25D9768Indefinite Delivery Contract
- SPE2DB25D9768-SPE2DB25FTTTLDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,128.96 to DMS Pharmaceutical Group Inc. on September 5, 2025, for the supply of IOSAT 130 mg tablets in quantities of 14 units. The contract is firm fixed-price with an ultimate completion date of September 8, 2025, and will be performed in Park Ridge, Illinois. This award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the open market despite its status as a woman-owned small business. DMS Pharmaceutical Group, a pharmaceutical wholesaler based in Park Ridge, Illinois, has maintained a robust federal contracting relationship with the Defense Logistics Agency since at least 2001. This delivery order is issued under the company's existing single-award Indefinite Delivery Contract with DLA valued at $499,999,999 through November 2026, which authorizes firm fixed-price orders for a comprehensive range of pharmaceutical items supporting military healthcare facilities. The company specializes in distributing branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to Department of Defense and other federal healthcare systems nationwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 9/5/25 |